In an age- and sex-adjusted model, baseline smoking (smoking less often than daily or former smoking), ALAT and aspartate aminotransferase (ASAT) concentrations as well as BMI and WC change during the study period were associated with NAFLD remission (Table 2). This evidence concerns the gene ABCB7 and metabolic dysfunction-associated steatotic liver disease.